---
figid: PMC4695139__oncotarget-06-23594-g005
figtitle: Identification of SPHK1 as a therapeutic target and marker of poor prognosis
  in cholangiocarcinoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4695139
filename: oncotarget-06-23594-g005.jpg
figlink: /pmc/articles/PMC4695139/figure/F5/
number: F5
caption: SK1-I modulates the balance of ceramide-S1P and directs the CCA cells into
  an apoptotic program. SK1-I and JTE-013 synergistically inhibit ERK and AKT signaling
  by affecting the SPHK1/S1P pathway at multiple nodes.
papertitle: Identification of SPHK1 as a therapeutic target and marker of poor prognosis
  in cholangiocarcinoma.
reftext: Ming-Huang Chen, et al. Oncotarget. 2015 Sep 15;6(27):23594-23608.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.956142
figid_alias: PMC4695139__F5
figtype: Figure
redirect_from: /figures/PMC4695139__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4695139__oncotarget-06-23594-g005.html
  '@type': Dataset
  description: SK1-I modulates the balance of ceramide-S1P and directs the CCA cells
    into an apoptotic program. SK1-I and JTE-013 synergistically inhibit ERK and AKT
    signaling by affecting the SPHK1/S1P pathway at multiple nodes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MBTPS1
  - S1PR2
  - SPHK1
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - S1PR1
---
